Literature DB >> 22809763

Serum cystatin C- versus creatinine-based definitions of acute kidney injury following cardiac surgery: a prospective cohort study.

Aferdita Spahillari1, Chirag R Parikh, Kyaw Sint, Jay L Koyner, Uptal D Patel, Charles L Edelstein, Cary S Passik, Heather Thiessen-Philbrook, Madhav Swaminathan, Michael G Shlipak.   

Abstract

BACKGROUND: The primary aim of this study was to compare the sensitivity and rapidity of acute kidney injury (AKI) detection by cystatin C level relative to creatinine level after cardiac surgery. STUDY
DESIGN: Prospective cohort study. SETTINGS & PARTICIPANTS: 1,150 high-risk adult cardiac surgery patients in the TRIBE-AKI (Translational Research Investigating Biomarker Endpoints for Acute Kidney Injury) Consortium. PREDICTOR: Changes in serum creatinine and cystatin C levels. OUTCOME: Postsurgical incidence of AKI. MEASUREMENTS: Serum creatinine and cystatin C were measured at the preoperative visit and daily on postoperative days 1-5. To allow comparisons between changes in creatinine and cystatin C levels, AKI end points were defined by the relative increases in each marker from baseline (25%, 50%, and 100%) and the incidence of AKI was compared based on each marker. Secondary aims were to compare clinical outcomes among patients defined as having AKI by cystatin C and/or creatinine levels.
RESULTS: Overall, serum creatinine level detected more cases of AKI than cystatin C level: 35% developed a ≥25% increase in serum creatinine level, whereas only 23% had a ≥25% increase in cystatin C level (P < 0.001). Creatinine level also had higher proportions meeting the 50% (14% and 8%; P < 0.001) and 100% (4% and 2%; P = 0.005) thresholds for AKI diagnosis. Clinical outcomes generally were not statistically different for AKI cases detected by creatinine or cystatin C level. However, for each AKI threshold, patients with AKI confirmed by both markers had a significantly higher risk of the combined mortality/dialysis outcome compared with patients with AKI detected by creatinine level alone (P = 0.002). LIMITATIONS: There were few adverse clinical outcomes, limiting our ability to detect differences in outcomes between subgroups of patients based on their definitions of AKI.
CONCLUSIONS: In this large multicenter study, we found that cystatin C level was less sensitive for AKI detection than creatinine level. However, confirmation by cystatin C level appeared to identify a subset of patients with AKI with a substantially higher risk of adverse outcomes. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22809763      PMCID: PMC3496012          DOI: 10.1053/j.ajkd.2012.06.002

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  30 in total

1.  Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery.

Authors:  Chirag R Parikh; Steven G Coca; Heather Thiessen-Philbrook; Michael G Shlipak; Jay L Koyner; Zhu Wang; Charles L Edelstein; Prasad Devarajan; Uptal D Patel; Michael Zappitelli; Catherine D Krawczeski; Cary S Passik; Madhav Swaminathan; Amit X Garg
Journal:  J Am Soc Nephrol       Date:  2011-08-11       Impact factor: 10.121

2.  Cystatin C: efficacy as screening test for reduced glomerular filtration rate.

Authors:  S Herget-Rosenthal; S Trabold; F Pietruck; M Holtmann; T Philipp; A Kribben
Journal:  Am J Nephrol       Date:  2000 Mar-Apr       Impact factor: 3.754

3.  Impact of thyroid dysfunction on serum cystatin C.

Authors:  Manuel Fricker; Peter Wiesli; Michael Brändle; Beat Schwegler; Christoph Schmid
Journal:  Kidney Int       Date:  2003-05       Impact factor: 10.612

4.  Independent association between acute renal failure and mortality following cardiac surgery.

Authors:  G M Chertow; E M Levy; K E Hammermeister; F Grover; J Daley
Journal:  Am J Med       Date:  1998-04       Impact factor: 4.965

5.  Preoperative renal risk stratification.

Authors:  G M Chertow; J M Lazarus; C L Christiansen; E F Cook; K E Hammermeister; F Grover; J Daley
Journal:  Circulation       Date:  1997-02-18       Impact factor: 29.690

6.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

7.  Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement.

Authors:  Eric L Knight; Jacobien C Verhave; Donna Spiegelman; Hans L Hillege; Dick de Zeeuw; Gary C Curhan; Paul E de Jong
Journal:  Kidney Int       Date:  2004-04       Impact factor: 10.612

8.  Early detection of acute renal failure by serum cystatin C.

Authors:  Stefan Herget-Rosenthal; Günter Marggraf; Johannes Hüsing; Frauke Göring; Frank Pietruck; Onno Janssen; Thomas Philipp; Andreas Kribben
Journal:  Kidney Int       Date:  2004-09       Impact factor: 10.612

9.  Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II System.

Authors:  E J Erlandsen; E Randers; J H Kristensen
Journal:  Scand J Clin Lab Invest       Date:  1999-02       Impact factor: 1.713

10.  Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine.

Authors:  D J Newman; H Thakkar; R G Edwards; M Wilkie; T White; A O Grubb; C P Price
Journal:  Kidney Int       Date:  1995-01       Impact factor: 10.612

View more
  34 in total

1.  Plasma IL-6 and IL-10 Concentrations Predict AKI and Long-Term Mortality in Adults after Cardiac Surgery.

Authors:  William R Zhang; Amit X Garg; Steven G Coca; Philip J Devereaux; John Eikelboom; Peter Kavsak; Eric McArthur; Heather Thiessen-Philbrook; Colleen Shortt; Michael Shlipak; Richard Whitlock; Chirag R Parikh
Journal:  J Am Soc Nephrol       Date:  2015-04-08       Impact factor: 10.121

Review 2.  A basic science view of acute kidney injury biomarkers.

Authors:  Jennifer R Charlton; Didier Portilla; Mark D Okusa
Journal:  Nephrol Dial Transplant       Date:  2014-01-02       Impact factor: 5.992

Review 3.  Cardiac surgery-associated acute kidney injury.

Authors:  Huijuan Mao; Nevin Katz; Wassawon Ariyanon; Lourdes Blanca-Martos; Zelal Adýbelli; Anna Giuliani; Tommaso Hinna Danesi; Jeong Chul Kim; Akash Nayak; Mauro Neri; Grazia Maria Virzi; Alessandra Brocca; Elisa Scalzotto; Loris Salvador; Claudio Ronco
Journal:  Cardiorenal Med       Date:  2013-10       Impact factor: 2.041

4.  Association of definition of acute kidney injury by cystatin C rise with biomarkers and clinical outcomes in children undergoing cardiac surgery.

Authors:  Michael Zappitelli; Jason H Greenberg; Steven G Coca; Catherine D Krawczeski; Simon Li; Heather R Thiessen-Philbrook; Michael R Bennett; Prasad Devarajan; Chirag R Parikh
Journal:  JAMA Pediatr       Date:  2015-06       Impact factor: 16.193

5.  Association of Peak Changes in Plasma Cystatin C and Creatinine With Death After Cardiac Operations.

Authors:  Meyeon Park; Michael G Shlipak; Heather Thiessen-Philbrook; Amit X Garg; Jay L Koyner; Steven G Coca; Chirag R Parikh
Journal:  Ann Thorac Surg       Date:  2016-02-26       Impact factor: 4.330

6.  The performance of contemporary cystatin C-based GFR equations in predicting gentamicin clearance.

Authors:  Paul K L Chin; Janice S C Chew-Harris; Christopher M Florkowski; Evan J Begg
Journal:  Br J Clin Pharmacol       Date:  2015-02       Impact factor: 4.335

7.  Comparison of serum creatinine and serum cystatin C as biomarkers to detect sepsis-induced acute kidney injury and to predict mortality in CD-1 mice.

Authors:  Asada Leelahavanichkul; Ana Carolina P Souza; Jonathan M Street; Victor Hsu; Takayuki Tsuji; Kent Doi; Lingli Li; Xuzhen Hu; Hua Zhou; Parag Kumar; Jürgen Schnermann; Robert A Star; Peter S T Yuen
Journal:  Am J Physiol Renal Physiol       Date:  2014-08-20

Review 8.  Biomarkers in nephrology: Core Curriculum 2013.

Authors:  Gearoid M McMahon; Sushrut S Waikar
Journal:  Am J Kidney Dis       Date:  2013-02-27       Impact factor: 8.860

Review 9.  Chronic kidney disease following acute kidney injury-risk and outcomes.

Authors:  Kelvin C W Leung; Marcello Tonelli; Matthew T James
Journal:  Nat Rev Nephrol       Date:  2012-12-18       Impact factor: 28.314

Review 10.  Update on cystatin C: incorporation into clinical practice.

Authors:  Michael G Shlipak; Monica D Mattes; Carmen A Peralta
Journal:  Am J Kidney Dis       Date:  2013-05-20       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.